Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
8.40
+0.28 (3.45%)
Mar 6, 2026, 4:00 PM EST - Market closed
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $26.95 million as of March 6, 2026. Its market cap has decreased by -20.68% in one year.
Market Cap
26.95M
Enterprise Value
4.65M
1-Year Change
-20.68%
Ranking
Category
Stock Price
$8.40
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $26.95M, a decrease of -97.18%. That is a compound annual growth rate of -44.72%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 27.78M |
| Kyntra Bio | 27.67M |
| BriaCell Therapeutics | 27.53M |
| IGC Pharma | 27.39M |
| Cue Biopharma | 27.35M |
| Evaxion | 26.86M |
| AEON Biopharma | 26.82M |
| Exicure | 26.45M |